Earnings Feed
Start Free
Home/Filings/4/0001127602-21-012812
4//SEC Filing

Roberts Jonathan C 4

Accession 0001127602-21-012812

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:59 PM ET

Size

22.5 KB

Accession

0001127602-21-012812

Insider Transaction Report

Form 4
Period: 2021-02-01
CVS HEALTH CorpCVS
Roberts Jonathan C
SVP and CIO
Transactions
  • Award

    Stock Option

    2021-04-01$74.30/sh+172,772$12,836,960→ 172,772 total
    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (172,772 underlying)
  • Award

    Common Stock

    2021-02-01+175,811→ 176,474.717 total
  • Tax Payment

    Common Stock

    2021-04-01$74.30/sh−79,714$5,922,750→ 96,760.717 total
Holdings

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (303,010 underlying)
    303,010

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (239,355 underlying)
    239,355

  • Common Stock

    (indirect: By GRAT)
    45,061

  • Common Stock (restricted)

    12,812

  • ESOP Common Stock

    (indirect: By ESOP)
    6,045

  • Phantom Stock Credits

    Exercise: $1.00→ Common Stock (1,422.671 underlying)
    1,422.671

  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (68,482 underlying)
    68,482

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (200,358 underlying)
    200,358

  • Stock Unit

    333,720.845

  • Stock Option

    Exercise: $45.93From: 2015-09-04Exp: 2022-09-04→ Common Stock (108,870 underlying)
    108,870

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (161,318 underlying)
    161,318

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (248,131 underlying)
    248,131
Footnotes (12)
  • [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.
  • [F10]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F11]The number of shares subject to the option were calculated using a 30-day average price.
  • [F12]Options became exercisable in four equal installments, commencing 4/1/2021.
  • [F2]Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.
  • [F3]Option becomes exercisable in four equal installments, commencing 4/1/2022.
  • [F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F5]Option became exercisable in three equal annual installments, commencing 9/4/2015.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F9]Option became exercisable in four equal annual installments, commencing 4/1/2019.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001410515

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:59 PM ET
Size
22.5 KB
View on SEC.gov